Tender detail
Non-exclusive discount agreement for clomipramine medicines
Summary
DAK-Gesundheit will conclude non-exclusive discount agreements with pharmaceutical companies for medicines containing clomipramine (ATC N06AA04). The agreements will run from 1 December 2026 to 30 November 2028, with one possible 12-month extension, and will end earlier if an exclusive agreement takes effect.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.